Another study in a prostate cancer mouse model showed that castration, although not sufficient to prevent invasive and resistant tumor growth, elicited enhanced T cell numbers within the prostate tumors as well as a higher CD8+/Foxp3+ T cell ratio. The gene discussed is CD8A; the disease is neoplasm.